EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review

Ana S Rodríguez-Báez, Nina Kreuzberger, Claire Iannizzi, Kamran Irfan, Frederike Lentz, Anna Krueger, Norbert Benda, Ulrich Jaehde

Clinical Pharmacokinetics · 2026-11 · 65 (11) · 1629-1666

DOI: 10.1007/s40262-026-01670-0 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 07.10.2026. Verfasst von Ana S Rodríguez-Báez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, An der Immenburg, 53121, Bonn, Germany. arodrigu@uni-bonn.de. Hauptthemen laut MEDLINE: Models, Biological, Pharmacokinetics. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the biggest challenges in the youngest paediatric population (≤ 2 years) is defining a safe and effective dose. Thus, growth and maturation are crucial aspects to consider when pharmacometric (PMX) approaches are applied to estimate key pharmacokinetic parameters that guide dose selection. Derived from this, diverse methodologies and mathematical functions have been proposed. However, there is currently no clear consensus on the use of pharmacometric approaches to guide model-based precision dosing in newborns, infants and toddlers.

Aim

This scoping review aimed to provide a comprehensive overview of the current research status on the use of pharmacometric models for precise dosing in neonates, infants and toddlers.

Methods

This scoping review was conducted in accordance with the Joanna Briggs Institute guidelines. MEDLINE and Embase were systematically searched from 1 January 2014 to 14 May 2025. Eligible were studies that applied PMX approaches in the youngest population. Data were extracted to identify scaling and maturation functions applied to guide paediatric dosing. Results were reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Review checklist.

Results

From 57 studies included, the most commonly applied PMX approaches were population pharmacokinetics (75%) followed by physiologically based pharmacokinetic modelling (25%). Main application areas included antimicrobial therapy (30%), antiepileptic therapy (12%) and antineoplastic therapy (10%). The most commonly used allometric approaches were the fixed allometric scaling exponent based on a power function (37%), diverse exponents on body weight (34%), anatomical and physiological scaling (19%), others (8%) and not reported (2%), with normalisation primarily to standard adult body weight (36%) or the median value (27%) and applied to total clearance, intercompartmental clearance and volume of distribution. Maturation functions were typically incorporated using sigmoidal (49%), power (8%), exponential (7%) or linear functions (4%), depending on post-menstrual or post-natal age.

Conclusion

This review provides an overview of commonly applied PMX approaches in paediatrics, emphasising the importance of including allometry and maturation functions, and shows the variety of methodological strategies used to guide paediatric dose selection in the youngest population. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalPharmacokineticsHumansInfantInfant, NewbornChild, PreschoolPharmaceutical PreparationsDose-Response Relationship, Drug

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, An der Immenburg, 53121, Bonn, Germany. arodrigu@uni-bonn.de.
  • Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany. arodrigu@uni-bonn.de.
  • Faculty of Medicine and University Hospital Cologne, Institute of Public Health, University of Cologne, Cologne, Germany.
  • National Institute of Research in Agronomy (INRA), Université d´Avignon et des Pays du Vaucluse, UMR Emmah, Avignon, France.
  • Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.
  • Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, An der Immenburg, 53121, Bonn, Germany.

Förderung

  • Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Rodríguez-Báez, A. S., Kreuzberger, N., Iannizzi, C., Irfan, K., Lentz, F., Krueger, A., Benda, N., & Jaehde, U. (2026). Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review. Clinical Pharmacokinetics, 65(11), 1629-1666. https://doi.org/10.1007/s40262-026-01670-0

Vancouver

Rodríguez-Báez AS, Kreuzberger N, Iannizzi C, Irfan K, Lentz F, Krueger A, et al. Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review. Clinical Pharmacokinetics. 2026;65(11):1629-1666. doi:10.1007/s40262-026-01670-0

BibTeX
@article{RodrguezBez2026,
  author = {Rodríguez-Báez, Ana S and Kreuzberger, Nina and Iannizzi, Claire and Irfan, Kamran and Lentz, Frederike and Krueger, Anna and Benda, Norbert and Jaehde, Ulrich},
  title = {Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review},
  journal = {Clinical Pharmacokinetics},
  year = {2026},
  volume = {65},
  number = {11},
  pages = {1629--1666},
  doi = {10.1007/s40262-026-01670-0}
}
Kostenlos starten →